Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 3 | Cost Effectiveness and Resource Allocation

Fig. 3

From: A cost-benefit analysis of mass prostate cancer screening

Fig. 3

Sensitivity analysis for NCBI of men PCa screening by PSA and DRE: in case of Complementary Information. DRC: Decrease Radiotherapy Complication, IRC: Increase Radiotherapy Complication, DSC: Decrease Surgery Complication, ISC: Increase Surgery Complication, DBC: Decrease Biopsy Complication, IBC: Increase Biopsy Complication

Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us